Business Description
Integrated Diagnostics Holdings PLC
ISIN : JE00BLKGSR75
Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.02 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | 1.23 | |||||
| Interest Coverage | 5.77 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.09 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.7 | |||||
| 3-Year EBITDA Growth Rate | -19 | |||||
| 3-Year EPS without NRI Growth Rate | -23.6 | |||||
| 3-Year FCF Growth Rate | -46.9 | |||||
| 3-Year Book Growth Rate | -15.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 18.86 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.35 | |||||
| 9-Day RSI | 86.57 | |||||
| 14-Day RSI | 78.99 | |||||
| 6-1 Month Momentum % | 6.06 | |||||
| 12-1 Month Momentum % | -20.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.59 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.76 | |||||
| Days Inventory | 118.94 | |||||
| Days Sales Outstanding | 113.78 | |||||
| Days Payable | 90.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -5.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.02 | |||||
| Operating Margin % | 18.16 | |||||
| Net Margin % | 21.62 | |||||
| FCF Margin % | 15.16 | |||||
| ROE % | 16.34 | |||||
| ROA % | 7.16 | |||||
| ROIC % | 5.35 | |||||
| 3-Year ROIIC % | 38.73 | |||||
| ROC (Joel Greenblatt) % | 28.63 | |||||
| ROCE % | 13.5 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.75 | |||||
| Forward PE Ratio | 12.36 | |||||
| PE Ratio without NRI | 23.75 | |||||
| Shiller PE Ratio | 8.21 | |||||
| Price-to-Owner-Earnings | 67.86 | |||||
| PS Ratio | 5.34 | |||||
| PB Ratio | 4.9 | |||||
| Price-to-Tangible-Book | 15 | |||||
| Price-to-Free-Cash-Flow | 36.54 | |||||
| Price-to-Operating-Cash-Flow | 29.69 | |||||
| EV-to-EBIT | 18.6 | |||||
| EV-to-EBITDA | 14.31 | |||||
| EV-to-Forward-EBITDA | 4.93 | |||||
| EV-to-Revenue | 5.78 | |||||
| EV-to-Forward-Revenue | 1.64 | |||||
| EV-to-FCF | 33.92 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-Graham-Number | 4.09 | |||||
| Earnings Yield (Greenblatt) % | 5.38 | |||||
| FCF Yield % | 2.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Integrated Diagnostics Holdings PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 49.713 | ||
| EPS (TTM) (€) | 0.018 | ||
| Beta | 0.37 | ||
| Volatility % | 53.09 | ||
| 14-Day RSI | 78.99 | ||
| 14-Day ATR (€) | 0.009869 | ||
| 20-Day SMA (€) | 0.35 | ||
| 12-1 Month Momentum % | -20.9 | ||
| 52-Week Range (€) | 0.224 - 0.45 | ||
| Shares Outstanding (Mil) | 581.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Integrated Diagnostics Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Integrated Diagnostics Holdings PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Integrated Diagnostics Holdings PLC Frequently Asked Questions
What is Integrated Diagnostics Holdings PLC(FRA:8I8)'s stock price today?
The current price of FRA:8I8 is €0.45. The 52 week high of FRA:8I8 is €0.45 and 52 week low is €0.22.
When is next earnings date of Integrated Diagnostics Holdings PLC(FRA:8I8)?
The next earnings date of Integrated Diagnostics Holdings PLC(FRA:8I8) is 2024-11-15 Est..
Does Integrated Diagnostics Holdings PLC(FRA:8I8) pay dividends? If so, how much?
Integrated Diagnostics Holdings PLC(FRA:8I8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers